tiprankstipranks
Trending News
More News >
Tri Chemical Laboratories Inc. (JP:4369)
:4369
Japanese Market
Advertisement

Tri Chemical Laboratories Inc. (4369) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4369

Tri Chemical Laboratories Inc.

(4369)

Rating:61Neutral
Price Target:
¥2,711.00
▲(7.92% Upside)
The overall stock score is primarily influenced by strong financial performance, despite cash flow challenges. Technical analysis indicates bearish momentum, which negatively impacts the score. Valuation is moderate, with no significant earnings call or corporate events to influence the score further.

Tri Chemical Laboratories Inc. (4369) vs. iShares MSCI Japan ETF (EWJ)

Tri Chemical Laboratories Inc. Business Overview & Revenue Model

Company DescriptionTri Chemical Laboratories Inc. is a company based in Japan that specializes in the development, manufacturing, and distribution of high-purity chemical materials. These materials are primarily utilized in the semiconductor and electronics industries, which require stringent quality standards and innovative solutions. The company is recognized for its advanced chemical technologies and commitment to quality, serving a diverse range of clients within the high-tech manufacturing sector.
How the Company Makes MoneyTri Chemical Laboratories Inc. generates revenue through the sale of its high-purity chemical products, which are essential in the production processes of semiconductors and electronic components. The company caters to a global clientele, including major semiconductor manufacturers, and derives income from both direct sales and long-term supply agreements. Key revenue streams include the production and distribution of chemical precursors, etchants, and other specialty chemicals. Tri Chemical Laboratories Inc. may also engage in strategic partnerships and collaborations with industry leaders to enhance its product offerings and market reach, contributing further to its financial performance.

Tri Chemical Laboratories Inc. Financial Statement Overview

Summary
Tri Chemical Laboratories Inc. demonstrates strong revenue growth and profitability with a solid balance sheet. However, cash flow challenges, particularly negative free cash flow, could pose risks if not addressed.
Income Statement
85
Very Positive
Tri Chemical Laboratories Inc. shows strong revenue growth with a 17.43% increase in TTM, indicating robust demand. The company maintains healthy profitability with a gross profit margin of 41.64% and a net profit margin of 24.13% in TTM. EBIT and EBITDA margins are also solid at 30.16% and 36.65%, respectively, reflecting efficient operations. However, slight declines in gross and net profit margins compared to previous periods suggest potential cost pressures.
Balance Sheet
78
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.0468, indicating low leverage and financial stability. Return on equity is healthy at 17.64%, showcasing effective use of equity to generate profits. The equity ratio stands at 80.71%, reflecting a solid equity base. However, the slight decrease in stockholders' equity over recent periods could be a point of concern.
Cash Flow
65
Positive
Operating cash flow remains positive, but the free cash flow is negative, indicating potential challenges in cash generation after capital expenditures. The operating cash flow to net income ratio is 0.36, suggesting moderate cash conversion efficiency. The negative free cash flow growth rate and free cash flow to net income ratio highlight potential liquidity concerns.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.20B18.91B11.25B13.80B11.57B9.80B
Gross Profit9.25B8.01B4.09B5.58B4.84B4.38B
EBITDA8.14B6.63B4.61B7.42B6.35B5.17B
Net Income5.36B4.96B2.47B4.83B4.10B3.38B
Balance Sheet
Total Assets38.80B36.94B31.86B32.12B28.29B19.87B
Cash, Cash Equivalents and Short-Term Investments7.99B9.44B10.50B11.14B8.03B1.70B
Total Debt1.47B1.78B2.40B3.24B4.28B5.05B
Total Liabilities7.49B5.36B4.29B6.24B6.97B7.27B
Stockholders Equity31.32B31.59B27.57B25.88B21.32B12.60B
Cash Flow
Free Cash Flow-1.10B605.75M1.19B4.84B2.71B-872.24M
Operating Cash Flow2.32B3.68B2.97B6.39B3.64B2.09B
Investing Cash Flow-3.48B-3.12B-1.78B-1.56B-932.88M-2.96B
Financing Cash Flow-1.96B-1.62B-1.86B-1.70B3.59B948.34M

Tri Chemical Laboratories Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2512.00
Price Trends
50DMA
3206.52
Negative
100DMA
2974.28
Negative
200DMA
2996.27
Negative
Market Momentum
MACD
-138.14
Positive
RSI
28.98
Positive
STOCH
6.39
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Negative. The current price of 2512 is below the 20-day moving average (MA) of 3022.30, below the 50-day MA of 3206.52, and below the 200-day MA of 2996.27, indicating a bearish trend. The MACD of -138.14 indicates Positive momentum. The RSI at 28.98 is Positive, neither overbought nor oversold. The STOCH value of 6.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4369.

Tri Chemical Laboratories Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥64.71B10.19
2.03%-1.66%-29.18%
77
Outperform
¥19.54B12.02
2.28%7.57%35.66%
74
Outperform
¥98.73B9.24
3.44%8.46%74.58%
69
Neutral
¥63.88B13.64
4.32%0.32%-43.10%
61
Neutral
$10.27B6.370.76%2.91%3.10%-36.03%
61
Neutral
¥81.47B14.27
1.40%71.39%87.22%
¥96.07B11.32
2.30%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4369
Tri Chemical Laboratories Inc.
2,512.00
-812.79
-24.45%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
4,625.00
-408.19
-8.11%
JP:4028
ISHIHARA SANGYO KAISHA, LTD.
2,471.00
1,069.90
76.36%
JP:4099
SHIKOKU KASEI HOLDINGS CORPORATION
2,186.00
269.75
14.08%
JP:4113
Taoka Chemical Co., Ltd.
1,359.00
456.85
50.64%
JP:4365
Matsumoto Yushiseiyaku Co., Ltd.
20,000.00
2,028.44
11.29%

Tri Chemical Laboratories Inc. Corporate Events

Tri Chemical Laboratories Reports Strong Q1 2025 Financial Growth
May 30, 2025

Tri Chemical Laboratories Inc. reported significant financial growth for the three months ended April 30, 2025, with net sales doubling and operating profit increasing by 157.6% compared to the previous year. This financial performance indicates a strong market position and potential positive implications for stakeholders, as the company maintains a robust capital adequacy ratio of 80.7% and forecasts continued growth in the fiscal year ending January 31, 2026.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Tri Chemical Laboratories Explores Joint Ventures in China
May 23, 2025

Tri Chemical Laboratories Inc. has signed a memorandum of understanding with Hefei ADChem Semi-Tech. Co., Ltd. to explore joint ventures in the Chinese semiconductor market. This collaboration aims to leverage ADChem’s technological capabilities and market presence in China, though it is expected to have minimal impact on Tri Chemical’s performance in the current fiscal year.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 02, 2025